Alcohol

Alcohol

SCHEMBL1345780

C1=Cc2cc3ccc(cc4nc(cc5ccc(cc1n2)[nH]5)C=C4)[nH]3.CCO

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.36
▸ STAT1 P42224 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL28281751 0.98 STAT3 (0.35) STAT3STAT1
Alcohol SCHEMBL28105960 0.98 STAT3 (0.35) STAT3STAT1
Alcohol SCHEMBL11138760 0.94 STAT3 (0.33) STAT3STAT1
Ethylene Glycol SCHEMBL28169592 0.89 STAT3 (0.37) STAT3STAT1
Methyl Alcohol SCHEMBL6497173 0.89 STAT3 (0.39) STAT3STAT1
Alcohol SCHEMBL10570857 0.88 STAT3 (0.31) STAT3STAT1
SCHEMBL8507482 0.88 STAT3 (0.36) STAT3STAT1
SCHEMBL28761349 0.88 STAT3 (0.36) STAT3STAT1
SCHEMBL27675579 0.88 STAT3 (0.36) STAT3STAT1
Ethyl Chloride SCHEMBL5174926 0.88 STAT3 (0.36) STAT3STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108117768-A A kind of essence package body nano catalytic material and its preparation method and application 湖北中烟工业有限责任公司 2018-06-05 — — CN claimed
CN-109926089-A The preparation method and application of the stable copper nanocatalyst of porphyrin 三峡大学 2019-06-25 — — CN disclosed
CN-109926088-A The preparation method and application of the stable palladium nanocatalyst of porphyrin 三峡大学 2019-06-25 — — CN disclosed
CN-106076420-B The preparation method and application of cadmium sulfide immobilized four (4- carboxyl phenyls) ferriporphyrin catalysis material 广西大学 2018-10-23 — — CN disclosed
CN-108117768-A A kind of essence package body nano catalytic material and its preparation method and application 湖北中烟工业有限责任公司 2018-06-05 — — CN disclosed
CN-106076420-A The preparation method and application of cadmium sulfide immobilized four (4 carboxyl phenyl) iron porphyrin catalysis material 广西大学 2016-11-09 — — CN disclosed
US-8669359-B2 Electrically conducting porphyrin and porphyrin-fullerene electropolymers ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2014-03-11 — — US disclosed
US-8529996-B2 High-temperature attachment of organic molecules to substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-09-10 — — US disclosed
US-8173630-B2 Multipodal tethers for high-density attachment of redox-active moieties to substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-05-08 — — US disclosed
US-8062756-B2 Stepwise growth of oligomeric redox-active molecules on a surface without the use of protecting groups The Regents oft the University of California (US) 2011-11-22 — — US disclosed
US-20050217559-A1 Attachment of organic molecules to group III, IV or V substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2005-10-06 — — US disclosed
US-6943054-B2 Attachment of organic molecules to group III, IV or V substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-09-13 — — US disclosed
US-6906050-B2 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis MIRAVANT PHARMACEUTICALS, INC. (US) 2005-06-14 — — US disclosed
US-20050048691-A1 High temperature attachment of organic molecules to substrates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2005-03-03 — — US disclosed
US-20050019500-A1 Coupling a heat resistant porphyrins derivatized with an attachment group to a silicon or germanium semiconductor surface by heating to at least 200 degrees Celsius; integrated circuits THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2005-01-27 — — US disclosed
EP-1401430-A1 SUBSTITUTED PORPHYRIN AND AZAPORPHYRIN DERIVATIVES AND THEIR USE IN PHOTODYNAMIC THERAPY, RADIOIMAGING AND MRI DIAGNOSIS Miravant Pharmaceuticals, Inc. (US) 2004-03-31 — — EP disclosed
US-20030100752-A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis MIRAVANT PHARMACEUTICALS, INC. 2003-05-29 — — US disclosed
WO-2003038886-A1 FORMATION OF SELF-ASSEMBLED MONOLAYERS ON SILICON SUBSTRATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-05-08 — — WO disclosed
US-20030081463-A1 Formation of self-assembled monolayers of redox sams on silicon for molecular memory applications THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-05-01 — — US disclosed
WO-2002096417-A1 SUBSTITUTED PORPHYRIN AND AZAPORPHYRIN DERIVATIVES AND THEIR USE IN PHOTODYNAMIC THERAPY, RADIOIMAGING AND MRI DIAGNOSIS MIRAVANT PHARMACEUTICALS, INC. (US) 2002-12-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100752-A1 Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis PPOX, HMBS, MPI STAT3 2078/4885STAT1 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback